Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/1991
09/25/1991EP0311616B1 Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases
09/25/1991EP0229823B1 Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
09/25/1991CN1054773A Hemoregulatory peptides
09/24/1991US5051441 Immunomodulators and cardiovascular disorders
09/24/1991US5051425 Therapeutic composition for combatting AIDS
09/24/1991US5051408 Antitumor agents and insulin
09/24/1991US5051402 Fungicides, immunosuppressants and antiphlogistic agents
09/24/1991US5051371 Polypeptides with cystine groups for diagnosis of cancer and the immune systems
09/20/1991WO1991014430A1 Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991CA2078669A1 Topically active ocular thiadiazole sulfonamide carbonic anhydrase
09/19/1991WO1991013899A1 Tricyclo compounds
09/19/1991WO1991013889A1 Immunosuppressive macrocyclic compounds
09/19/1991WO1991013632A1 Idiotypic vaccination against b cell lymphoma
09/19/1991WO1991004058A3 Treatment of conditions and disease
09/18/1991EP0447353A1 A pharmaceutical preparation for the maturation of prothymocytes
09/18/1991EP0447324A1 2,4-Pyrimidinedione derivatives and medicines containing them
09/18/1991EP0447189A1 5-Hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors
09/18/1991EP0446931A1 Human ciliary neuronotrophic factor, DNA sequence encoding the factor, and production of the factor by recombinant technology
09/18/1991EP0446763A2 Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody
09/18/1991EP0446230A1 Treatment of myelosuppression associated with acquired immune deficiency
09/17/1991WO1991013622A1 Use of spiperone as an immunosuppressant and anti-inflammatory agent
09/17/1991US5049679 Carboxamide derivatives
09/17/1991US5049659 Proteins which induce immunological effector cell activation and chemattraction
09/17/1991US5049637 5-hydroxytryptamine antagonist
09/17/1991US5049576 Carboxamide derivatives
09/17/1991US5049568 Antihistamine, antiallergy, bronchodialtors
09/17/1991US5049380 Plant extracts
09/17/1991CA1289144C N-substituted 2-amino-thiazoles, process for their preparation and their therapeutic application
09/16/1991CA2038198A1 2,4-pyrimidinedione derivatives and pharmaceutical compositions containing them
09/15/1991CA2038208A1 Process for the isolation and expression of the human ciliary neuronotrophic factor by recombinant dna technology
09/12/1991DE4007315A1 Use of zinc-calcium hydroxide gel, lecithin and poly-alpha-olefin! - as adjuvants to increase immunogenicity of antigens, are of low toxicity and work synergistically
09/11/1991EP0446143A2 Polysaccharidic delipidated compounds, process for their preparation and compositions containing them
09/11/1991EP0445975A1 New hydroxymacrolide derivatives having immunosuppressive activity
09/11/1991EP0445971A1 DNA encoding a major mite allergen and the use thereof
09/11/1991EP0445710A1 Use of zinc-calcium hydroxyde, lecithin and PAO for adjuvating antigen solutions and antigen solutions adjuvated in this way
09/11/1991EP0445581A1 Stable immunostimulating preparation for parenteral application, preparation and use thereof
09/11/1991EP0445228A1 Immunotherapy involving cd28 stimulation
09/11/1991CN1013863B 5-chloro-s-triazole (4.3-alpha)-pyridine-7-carboxylic acids
09/10/1991WO1991013910A1 Peptides stimulating cytotoxic t cells immune to hiv rt
09/10/1991WO1991013892A1 New organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it
09/10/1991US5047593 Lipoxygenase inhibiting compounds
09/10/1991US5047575 Norbornene carboxylic acids and esters
09/10/1991US5047404 Chemical compounds
09/10/1991US5047400 Treatment of infection; antitumor agents
09/10/1991US5047396 Intravenous pharmaceutical composition and process for preparing the same
09/10/1991CA2077645A1 Organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it
09/09/1991CA2037741A1 Delipidated polysaccharide composition, method for preparing same
09/07/1991CA2037531A1 Preparation, which stimulates the immune system, can be applied parenterally and has a long shelf life, and method forproducing it
09/06/1991WO1991013883A1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity
09/06/1991CA2077543A1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity
09/05/1991WO1991012816A1 Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens
09/05/1991WO1991012812A1 Inhibitors of catalytic antibodies
09/05/1991WO1991012810A1 Immunosuppressant
09/05/1991WO1991010722A3 Chimeric immunoglobulin for cd4 receptors
09/04/1991EP0444931A2 Use of 3-oxygermylpropionic acid to treat and prevent diabetes due to autoimmune diseases
09/04/1991EP0444899A2 Catechol derivatives, their physiologically acceptable salts, esters and their use in the treatment of tissue damage induced by lipid peroxidation
09/04/1991EP0444897A1 Novel immunosuppressive cyclosporin analogs with modified amino acids at position-8
09/04/1991EP0444829A2 Immunosuppressive compounds
09/04/1991EP0444659A2 A pharmaceutical solution comprising derivatives of FK506
09/04/1991EP0444560A1 Antibody specific for the tumor necrosis factor receptor
09/04/1991EP0444549A1 Imidazopyridazines their production and use
09/04/1991EP0444208A1 Lipid a monosaccharide analog
09/04/1991EP0444129A1 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
09/04/1991CN1013769B Method for preparation of improvement leukotriene antagonists
09/03/1991WO1991013087A1 Hybrid compound purification
09/03/1991US5045548 Quinolyl methoxy compounds and their use as antiasthmatic agents
09/03/1991US5045547 Leukotriene-inhibiting substituted (quinolin-2-yl-methoxy)phenyl-N,N'-sulphonylureas and use thereas
09/03/1991US5045541 Immunodeficiency disorders
09/03/1991US5045320 Large multivalent immunogen
09/03/1991CA2077340A1 Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens
09/03/1991CA2077338A1 Hybrid compound purification
09/03/1991CA1288340C Interleukin-2 composition
09/02/1991CA2037300A1 Hydroxymacrolide derivatives having immunosuppressive activity
08/1991
08/29/1991WO1991012798A1 Process and composition for the treating of injuries caused by the radiation of heat and light
08/29/1991DE4104308A1 Therapeutische verwendung von somatostatinpeptiden Therapeutic use of somatostatinpeptiden
08/29/1991DE4006269A1 Antibody which binds to tumour necrosis factor receptors
08/29/1991CA2050285A1 Process and composition for the treating of injuries caused by the radiation of heat and light
08/29/1991CA2037199A1 Inhibitors of catalytic antibodies
08/28/1991EP0443559A2 HIV protease inhibiting agents
08/28/1991EP0443404A1 Peptide fragments and analogs of thrombospondin
08/28/1991EP0443198A2 Diterpenes with immunomodulatory activity
08/28/1991EP0443021A1 Novel use of vitamin d compounds to inhibit replication of the aids virus
08/28/1991CN1054066A Improvements in and relating to leukotriene antagonists
08/28/1991CN1013687B Tricycle compounds, a process for their production and a pharmaceutical composition containing the same
08/28/1991CA2036963A1 Immunosuppressive cyclosporin analogs with modified amino acids at position-8
08/27/1991US5043482 New derivatives of 5,6,7,8-tetrahydro-1-naphthalenol, a process for their preparation and cosmetic and pharmaceutical compositions containing them
08/27/1991US5043457 2(5H)-furanones substituted in the 3 position, as Ca2+ channel antagonists and anti-inflammatory agents
08/27/1991US5043335 Enzyme inhibitors; cardiovascular and central nervous system disorders
08/23/1991WO1991012804A1 New use
08/23/1991CA2036093A1 Peptide fragments and analogs of thrombospondin
08/22/1991WO1991012274A1 Bacterial peptide fraction with an immunostimulatory effect, process for making it and its use
08/22/1991DE4005159A1 Use of new and known sugar-substd. di:terpene(s) - as immuno:modulator(s), esp. for stimulating T-cells
08/21/1991EP0442820A1 Benzimidazole and azabenzimidazole derivatives, thromboxane receptor antagonists, processes for their preparation, synthesis intermediates, compositions containing them
08/21/1991EP0442748A1 Improvements in and relating to leukotriene antagonists
08/21/1991EP0442538A1 High purified protein, production and use thereof
08/21/1991EP0442204A2 Pyrimidopyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
08/20/1991US5041673 Novel tetralin derivatives
08/20/1991US5041639 Polysubstituted derivatives of naphtalene, their process of preparation and their application in the cosmetic and pharmaceutical fields
08/20/1991US5041535 Antileukemic and immunostimulant peptides
08/20/1991US5041462 Novel substituted acetamide compounds and use as anti-allergic agents
1 ... 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 ... 1172